Biotech News
Related news
RXSTRxSight2026-07-06 20:15 EST
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
SHCSotera Health2026-08-06 11:00 EST
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
CVRXCVRx2026-08-06 20:05 EST
CVRx Reports Second Quarter 2026 Financial and Operating Results
ICUIICU Medical2026-08-06 20:05 EST
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
PLSEPulse Biosciences2026-08-06 20:05 EST
Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
DNLIDenali Therapeutics2026-08-06 20:01 EST
Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
DCTHDelcath Systems2026-08-06 12:01 EST
Delcath Systems Reports Second Quarter 2026 Results and Business Highlights
MMSIMerit Medical2026-07-30 20:05 EST
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
ACHCAcadia Healthcare2026-07-28 20:05 EST
Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance
STIMNeuronetics2026-07-28 12:30 EST
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
RxSight
Adjustable Cataract Lenses RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery. Light Adjustable Lens System The system combines an implantable Light Adjustable Lens with a Light Delivery Device. After surgery, physicians use ultraviolet light treatments to modify the lens and refine the...
Recent company news
RXSTRxSight2026-08-05 20:05 EST
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
RXSTRxSight2026-07-26 20:00 EST
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
RXSTRxSight2026-07-15 20:15 EST
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
RXSTRxSight2026-07-06 20:16 EST
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
RXSTRxSight2026-07-06 20:15 EST
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
Stock data
- Close
- 6.08 USD
- Market cap
- 204.5M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States